Volume 42 Issue 4
Apr.  2021
Turn off MathJax
Article Contents
Na LI, Jie CHEN, Ji LUO, Yong-gang CHEN, Jiang-li PENG, Ming-li YU, Sheng-hao LI. Retrospective Analysis of 376 Cases of Adverse Reactions to Antituberculosis Drug[J]. Journal of Kunming Medical University, 2021, 42(4): 117-121. doi: 10.12259/j.issn.2095-610X.S20210422
Citation: Na LI, Jie CHEN, Ji LUO, Yong-gang CHEN, Jiang-li PENG, Ming-li YU, Sheng-hao LI. Retrospective Analysis of 376 Cases of Adverse Reactions to Antituberculosis Drug[J]. Journal of Kunming Medical University, 2021, 42(4): 117-121. doi: 10.12259/j.issn.2095-610X.S20210422

Retrospective Analysis of 376 Cases of Adverse Reactions to Antituberculosis Drug

doi: 10.12259/j.issn.2095-610X.S20210422
  • Received Date: 2020-12-11
  • Publish Date: 2021-04-01
  •   Objective   To explore the specific types, occurrence time and age structure of adverse reaction (ADR) in tuberculosis patients after anti-tuberculosis treatment, so as to provide certain reference for rational, safe and effective drug use in clinical practice.   Methods   The data of 376 patients with adverse reactions due to antituberculosis drugs admitted to Kunming Third People’ s Hospital from January 2015 to December 2019 were collected, and the data were analyzed using SPSS software.   Results   The occurrence of ADR in patients after anti-tuberculosis treatment was mostly likely to occur in the first 10 days, and the incidence of ADR in males was higher than that in females, but the difference was not statistically significant. The incidence of hepatotoxicity in TB patients after taking rifampicin (RFP) and isoniazid (INH) was higher (P < 0.05), and the incidence of hyperuricemia in TB patients after taking pyrazinamide (PZA) was higher (P < 0.05). The incidence of pruritus was higher in patients taking ethambutol (EMB) (P < 0.05).   Conclusion   ADRs caused by antituberculosis drugs are mostly hyperuricemia, pruritus, rash, liver damage, etc. Patients may develop ADRs within 10 days of initial dose. Therefore, clinicians should pay special attention to high-risk groups to reduce the occurence of ADR after medication.
  • loading
  • [1]
    Kerkhoff A D,Havlir D V. Virtual croi 2020:Tuberculosis and coinfections in hiv infection[J]. Topics In Antiviral Medicine,2020,28(2):455-458.
    [2]
    Loutet M G,Davidson J A,Brown T,et al. Acquired resistance to antituberculosis drugs in England,wales,and northern ireland,2000—2015[J]. Emerging Infectious Diseases,2018,24(3):524-533. doi: 10.3201/eid2403.171362
    [3]
    Walker T M,Cruz A L G,Peto T E,et al. Tuberculosis is changing[J]. The Lancet Infectious Diseases,2017,17(4):359-361. doi: 10.1016/S1473-3099(17)30123-8
    [4]
    Wang Y,Xiang X,Huang W W,et al. Association of pxr and car polymorphisms and antituberculosis drug-induced hepatotoxicity[J]. Scientific Reports,2019,9(1):1-9.
    [5]
    Migliori G B,Global Tuberculosis Network (GTN). Evolution of programmatic definitions used in tuberculosis prevention and care[J]. Clinical Infectious Diseases,2019,68(10):1787-1789. doi: 10.1093/cid/ciy990
    [6]
    Singla R,Sharma S K,Mohan A,et al. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity[J]. Indian Journal of Medical Research,2010,132(1):81-87.
    [7]
    Bansal A,Agrawal A,Sharma L,et al. A comparative study of active and passive adverse drug reaction reporting systems in terms of false reporting rate[J]. Scripta Medica,2020,51(4):223-230. doi: 10.5937/scriptamed51-29065
    [8]
    彭惠,申恩瑞,马世武. 吡嗪酰胺诱导的高尿酸血症[J]. 传染病信息,2018,31(4):376-380. doi: 10.3969/j.issn.1007-8134.2018.04.019
    [9]
    Xia H,Van Den Hof S,Cobelens F,et al. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant mycobacterium tuberculosis in china[J]. Bmc Infectious Diseases,2020,20(1):1-10. doi: 10.1186/s12879-019-4717-5
    [10]
    Pham A Q,Doan A,Andersen M. Pyrazinamide-induced hyperuricemia[J]. Pharmacy And Therapeutics,2014,39(10):695-697.
    [11]
    Xu B Y,Tang X D,Chen J,et al. Rifampicin induces clathrin-dependent endocytosis and ubiquitin–proteasome degradation of mrp2 via oxidative stress-activated pkc-erk/jnk/p38 and pi3k signaling pathways in hepg2 cells[J]. Acta Pharmacologica Sinica,2020,41(1):56-64. doi: 10.1038/s41401-019-0266-0
    [12]
    Son C G,Son C G. A severe hepatotoxicity by antituberculosis drug,and its recovery in oriental hospital[J]. Journal of Korean Medicine,2016,37(2):119-124. doi: 10.13048/jkm.16028
    [13]
    Zhang Jin Xin,Chen Juan Juan,Peng Jie. Research progress of anti-tuberculosis drug-induced liver injury[J]. Electronic Journal of Emerging Infectious Diseases,2019,4(3):173-176.
    [14]
    马玉炯,张倩,兀威. 抗结核药物不良反应研究进展[J]. 山东医药,2019,59(32):111-113. doi: 10.3969/j.issn.1002-266X.2019.32.031
    [15]
    王玉鹏,鲍婕. 异烟肼致肝损伤发病机制的研究进展[J]. 药学实践杂志,2019,37(4):289-293. doi: 10.3969/j.issn.1006-0111.2019.04.001
    [16]
    Sharma P,Kumar A,Singh P. A study of gender differentials in the prevalence of tuberculosis based on nfhs-2 and nfhs-3 data[J]. Indian Journal of Community Medicine:Official Publication of Indian Association of Preventive & Social Medicine,2010,35(2):230-237.
    [17]
    韩珂卿,栾飞,刘道恒,等. 结核病专科医院药品不良反应回顾性分析[J]. 临床肺科杂志,2019,24(8):1459-1462. doi: 10.3969/j.issn.1009-6663.2019.08.025
    [18]
    Kuyinu Y A,Odugbemi B A,Salisu Olatunji S O,et al. Characteristics of mycobacterium tuberculosis positive patients screened for drug-resistant tuberculosis at a tertiary health facility in Lagos,Nigeria[J]. Journal of the National Medical Association,2018,110(1):88-91. doi: 10.1016/j.jnma.2017.04.007
    [19]
    Silva D R,Muñoz Torrico M,Duarte R,et al. Risk factors for tuberculosis:diabetes,smoking,alcohol use,and the use of other drugs[J]. Jornal Brasileiro De Pneumologia,2018,44(2):145-152. doi: 10.1590/s1806-37562017000000443
    [20]
    Carroll M,Lee M,Cai Y,et al. Frequency of adverse reactions to first-and second-line anti-tuberculosis chemotherapy in a korean cohort[J]. The International Journal of Tuberculosis and Lung Disease,2012,16(7):961-966. doi: 10.5588/ijtld.11.0574
  • Relative Articles

    [1] Jihong LIU, Zhiqiang MA, Lin WANG, Xiaoyan WANG, Weiguang TIAN, Baoping LI, Rui DONG, Yujia LV. Correlation Analysis of Immune Function of Tuberculosis Patients Infected with COVID-19. Journal of Kunming Medical University, 2024, 45(4): 157-162.  doi: 10.12259/j.issn.2095-610X.S20240423
    [2] Wenxiu XU, Xiaofeng MO, Xiangmin YANG, Silu YANG, Fan WU, Te LI. Application of Logistic Regression and Decision Tree Model in Prediction of Adverse Reactions of Iodinated Contrast Medium. Journal of Kunming Medical University, 2024, 45(7): 1-6.
    [3] Zhen XU, Yu LING, Sixiang LIU, Yu SONG, Yang PENG, Jingjing SUN. Adverse Reactions of Vaccine Vaccination in Children with Special Health Conditions in Kunming and Countermeasures. Journal of Kunming Medical University, 2024, 45(3): 141-145.  doi: 10.12259/j.issn.2095-610X.S20240321
    [4] Zhe GE, Si-ping LU, Shi-zhong FU, Chun-hong WANG, Shao-ying LI, Ao LIU. The Preliminary Application of Whole Blood Interferon-Gamma Release Assay Combined with T Lymphocyte Subset Detection in Diagnosis of Pulmonary Tuberculosis. Journal of Kunming Medical University, 2021, 42(9): 108-113.  doi: 10.12259/j.issn.2095-610X.S20210901
    [5] Ran Hai Liang , Yang Qing Huan , Chen Ying , Xiong Li Fen , Deng Yi Yu , He Xiu Yun . . Journal of Kunming Medical University, 2020, 41(06): 46-50.
    [6] Rong WAN, Ming-wu LI, Meng MA, Ming-hong LAI, Guang-mei Li. Efficacy of T-SPOT.TB in Treatment of Active Tuberculosis. Journal of Kunming Medical University, 2020, 41(12): 133-137.  doi: 10.12259/j.issn.2095-610X.S20201237
    [7] Xing LIU, Bing OUYANG, Na LI, Ji LUO, Xu-qin SHI, Jie CHEN, Hui SUN, Hai-wen LI. Effect and Economic Evaluation of the Combination of Traditional Chinese and Western Medicine in Treatment of MDR-TB. Journal of Kunming Medical University, 2020, 41(11): 49-55.  doi: 10.12259/j.issn.2095-610X.S20201106
    [8] Li De Ying , Wang Yu Ming , Chai Hua Xiang , Dong Wei Qun . . Journal of Kunming Medical University, 2019, 40(11): 59-62.
    [9] Zhang Le , Xia Jia Wei , Chen Hai Yun , Huang Ying . . Journal of Kunming Medical University, 2018, 39(11): 93-97.
    [10] Liu Li , Wang Ya Ling , Bai Jing Song , Wang Li Xi , Wang Wei Bo , Chen Xiao Juan . Application of Cluster Nursing in Mechanical Ventilation Treatment of HIV Infection Complicated with Pulmonary Tuberculosis. Journal of Kunming Medical University, 2017, 38(07): 147-150.
    [11] Liu Ping . Effect of Intravenous Injection of Dezocine on the Incidence of Adverse Reactions during the Operation of Cesarean Delivery. Journal of Kunming Medical University,
    [12] Liu Qing Hua . The Effect of Propofor Combined with Shufen on Analgesia,Analepsia and Adverse Reactions of Laparoscopic Myomectomy. Journal of Kunming Medical University,
    [13] Hong Xu Hua . Effects of Tuberculosis Drugs Combined with Rifapentine on the Immune Function, Inflammatory Factors, VEGF and MMP-9 of TB Patients. Journal of Kunming Medical University,
    [14] Lu Ni Hong . . Journal of Kunming Medical University,
    [15] Gui Qi . . Journal of Kunming Medical University,
    [16] Tang Hui Rong . . Journal of Kunming Medical University,
    [17] Lu Ni Hong . . Journal of Kunming Medical University,
    [18] Zhang Ying . . Journal of Kunming Medical University,
    [19] Lu Ni Hong . Clinical Characteristics of Pulmonary Tuberculosis Patients with and without HIV(+)/AIDS. Journal of Kunming Medical University,
    [20] . The Clinical Analysis of 60 Cases of Adverse Reactions caused by Blood Transfusion. Journal of Kunming Medical University,
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(6)

    Article Metrics

    Article views (3347) PDF downloads(10) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return